Literature DB >> 17569965

Improved visibility of the subthalamic nucleus on high-resolution stereotactic MR imaging by added susceptibility (T2*) contrast using multiple gradient echoes.

E Elolf1, V Bockermann, T Gringel, M Knauth, P Dechent, G Helms.   

Abstract

Reliable identification of the subthalamic nucleus (STN) is a critical step in deep brain stimulation for Parkinson disease but difficult on T1-weighted stereotactic MR imaging. By simultaneous imaging of multiple gradient echoes, susceptibility contrast is added to conventional T1-weighted high-resolution MR image. Thus, the visibility of the STN is enhanced on a second co-localized dataset by exploiting the sensitivity of the T2*-relaxation to local iron deposits. The feasibility is underpinned by quantitative measurements on healthy adults.

Entities:  

Mesh:

Year:  2007        PMID: 17569965      PMCID: PMC8134154          DOI: 10.3174/ajnr.A0527

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  8 in total

Review 1.  Targeting the subthalamic nucleus.

Authors:  T Z Aziz; D Nandi; S Parkin; X Liu; N Giladi; P Bain; R G Gregory; C Joint; R B Scott; J F Stein
Journal:  Stereotact Funct Neurosurg       Date:  2001       Impact factor: 1.875

2.  Direct visualization of the human subthalamic nucleus with 3T MR imaging.

Authors:  K V Slavin; K R Thulborn; C Wess; H Nersesyan
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

3.  Rapid three-dimensional MR imaging using the FLASH technique.

Authors:  J Frahm; A Haase; D Matthaei
Journal:  J Comput Assist Tomogr       Date:  1986 Mar-Apr       Impact factor: 1.826

4.  MR imaging of human brain at 3.0 T: preliminary report on transverse relaxation rates and relation to estimated iron content.

Authors:  N Gelman; J M Gorell; P B Barker; R M Savage; E M Spickler; J P Windham; R A Knight
Journal:  Radiology       Date:  1999-03       Impact factor: 11.105

5.  Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data.

Authors:  Didier Dormont; Kenneth G Ricciardi; Dominique Tandé; Karine Parain; Carole Menuel; Damien Galanaud; Soledad Navarro; Philippe Cornu; Yves Agid; Jérôme Yelnik
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

Review 6.  High-field magnetic resonance imaging of brain iron: birth of a biomarker?

Authors:  John F Schenck; Earl A Zimmerman
Journal:  NMR Biomed       Date:  2004-11       Impact factor: 4.044

Review 7.  Subthalamic stimulation for Parkinson's disease.

Authors:  A L Benabid; A Koudsié; A Benazzouz; V Fraix; A Ashraf; J F Le Bas; S Chabardes; P Pollak
Journal:  Arch Med Res       Date:  2000 May-Jun       Impact factor: 2.235

8.  Determining the position and size of the subthalamic nucleus based on magnetic resonance imaging results in patients with advanced Parkinson disease.

Authors:  Erich O Richter; Tasnuva Hoque; William Halliday; Andres M Lozano; Jean A Saint-Cyr
Journal:  J Neurosurg       Date:  2004-03       Impact factor: 5.115

  8 in total
  12 in total

1.  Direct visualization of the subthalamic nucleus and its iron distribution using high-resolution susceptibility mapping.

Authors:  Andreas Schäfer; Birte U Forstmann; Jane Neumann; Sam Wharton; Alexander Mietke; Richard Bowtell; Robert Turner
Journal:  Hum Brain Mapp       Date:  2011-09-20       Impact factor: 5.038

2.  Optimal MRI methods for direct stereotactic targeting of the subthalamic nucleus and globus pallidus.

Authors:  Ruth L O'Gorman; Karin Shmueli; Keyoumars Ashkan; Michael Samuel; David J Lythgoe; Asal Shahidiani; Stephen J Wastling; Michelle Footman; Richard P Selway; Jozef Jarosz
Journal:  Eur Radiol       Date:  2010-07-21       Impact factor: 5.315

3.  In vivo normative atlas of the hippocampal subfields using multi-echo susceptibility imaging at 7 Tesla.

Authors:  Maged Goubran; David A Rudko; Brendan Santyr; Joe Gati; Trevor Szekeres; Terry M Peters; Ali R Khan
Journal:  Hum Brain Mapp       Date:  2013-12-13       Impact factor: 5.038

4.  Three-dimensional fluid-attenuated inversion recovery sequence for visualisation of subthalamic nucleus for deep brain stimulation in Parkinson's disease.

Authors:  Young Jin Heo; Sang Joon Kim; Ho Sung Kim; Choong Gon Choi; Seung Chai Jung; Jung Kyo Lee; Chong Sik Lee; Sun J Chung; So Hyun Cho; Gyoung Ro Lee
Journal:  Neuroradiology       Date:  2015-07-09       Impact factor: 2.804

5.  Efficient imaging of midbrain nuclei using inverse double-echo steady-state acquisition.

Authors:  Ming-Long Wu; Hing-Chiu Chang; Tzu-Cheng Chao; Nan-Kuei Chen
Journal:  Med Phys       Date:  2015-07       Impact factor: 4.071

6.  A multi-modal approach to computer-assisted deep brain stimulation trajectory planning.

Authors:  Silvain Bériault; Fahd Al Subaie; D Louis Collins; Abbas F Sadikot; G Bruce Pike
Journal:  Int J Comput Assist Radiol Surg       Date:  2012-06-21       Impact factor: 2.924

7.  Automated optimization of subcortical cerebral MR imaging-atlas coregistration for improved postoperative electrode localization in deep brain stimulation.

Authors:  T Schönecker; A Kupsch; A A Kühn; G-H Schneider; K-T Hoffmann
Journal:  AJNR Am J Neuroradiol       Date:  2009-08-27       Impact factor: 3.825

8.  A gradual increase of iron toward the medial-inferior tip of the subthalamic nucleus.

Authors:  Gilles de Hollander; Max C Keuken; Pierre-Louis Bazin; Marcel Weiss; Jane Neumann; Katja Reimann; Miriam Wähnert; Robert Turner; Birte U Forstmann; Andreas Schäfer
Journal:  Hum Brain Mapp       Date:  2014-03-04       Impact factor: 5.038

Review 9.  The conundrum of iron in multiple sclerosis--time for an individualised approach.

Authors:  Susan J van Rensburg; Maritha J Kotze; Ronald van Toorn
Journal:  Metab Brain Dis       Date:  2012-03-17       Impact factor: 3.584

Review 10.  Neuroimaging and deep brain stimulation.

Authors:  D Dormont; D Seidenwurm; D Galanaud; P Cornu; J Yelnik; E Bardinet
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-12       Impact factor: 4.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.